These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1742849)

  • 1. Bayesian estimation of doxorubicin pharmacokinetic parameters.
    Bressolle F; Ray P; Jacquet JM; Brès J; Galtier M; Donadio D; Jourdan J; Rossi JF
    Cancer Chemother Pharmacol; 1991; 29(1):53-60. PubMed ID: 1742849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of patients with impaired hepatic drug metabolism using a limited sampling procedure for estimation of phenazone (antipyrine) pharmacokinetic parameters.
    Fabre D; Bressolle F; Goméni R; Bouvet O; Dubois A; Raffanel C; Gris JC; Galtier M
    Clin Pharmacokinet; 1993 Apr; 24(4):333-43. PubMed ID: 8491059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A limited sampling procedure for estimating adriamycin pharmacokinetics in cancer patients.
    Launay MC; Milano G; Iliadis A; Frenay M; Namer N
    Br J Cancer; 1989 Jul; 60(1):89-92. PubMed ID: 2803920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin.
    Garraffo R; Iliadis A; Cano JP; Dellamonica P; Lapalus P
    J Pharm Sci; 1989 Sep; 78(9):753-7. PubMed ID: 2585270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients.
    Sabot C; Marquet P; Debord J; Carpentier N; Merle L; Lachâtre G
    Eur J Clin Pharmacol; 1998 Apr; 54(2):171-5. PubMed ID: 9626924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an optimal sampling strategy for clinical pharmacokinetic studies of the novel anthracycline disaccharide analogue MEN-10755.
    Bos AM; Boom K; Vinks AA; Boezen HM; Wanders J; Dombernovsky P; Aamdal S; de Vries EG; Uges DR
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):64-70. PubMed ID: 15069581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE; Würthwein G; Joachim B; Boddy AV; Krischke M; Fuhr U; Thompson PA; Jörger M; Schellens JH; Hempel G
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in non-small-cell lung cancer patients.
    Embree L; Gelmon KA; Lohr A; Mayer LD; Coldman AJ; Cullis PR; Palaitis W; Pilkiewicz F; Hudon NJ; Heggie JR
    J Pharm Sci; 1993 Jun; 82(6):627-34. PubMed ID: 8392545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal sampling strategies for bayesian estimation of docetaxel (Taxotere) clearance.
    Baille P; Bruno R; Schellens JH; Webster LK; Millward M; Verweij J; Montay G
    Clin Cancer Res; 1997 Sep; 3(9):1535-8. PubMed ID: 9815840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of population pharmacokinetic parameters in the presence of non-compliance.
    Mu S; Ludden TM
    J Pharmacokinet Pharmacodyn; 2003 Feb; 30(1):53-81. PubMed ID: 12800807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bayesian estimation of pharmacokinetic parameters of etoposide].
    Evene E; Chatelut E; Tranchand B; Canal P; Lochon I; Iliadis A; Ardiet CJ
    Bull Cancer; 1997 Jul; 84(7):699-703. PubMed ID: 9339195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Populational pharmacokinetics of doxorubicin applied to personalised its dosing in cancer patients].
    Escudero-Ortiz V; Ramón-López A; Duart MA; Pérez-Ruixo JJ; Valenzuela B
    Farm Hosp; 2012; 36(4):282-91. PubMed ID: 22129650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors.
    Tranchand B; Catimel G; Lucas C; Sarkany M; Bastian G; Evene E; Guastalla JP; Négrier S; Rebattu P; Dumortier A; Foy M; Grossin F; Mazier B; Froudarakis M; Barbet N; Clavel M; Ardiet C
    Cancer Chemother Pharmacol; 1998; 41(4):281-91. PubMed ID: 9488597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW; Hulot JS; Urien S; Morel V; Kaloshi G; Fernandez C; Xuan kH; Leblond V; Lechat P
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A.
    Bolon-Larger M; Chamouard V; Bressolle F; Boulieu R
    Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing population pharmacokinetic parameters for high-dose methotrexate therapy: implication of correlations among developed parameters for individual parameter estimation using the Bayesian least-squares method.
    Watanabe M; Fukuoka N; Takeuchi T; Yamaguchi K; Motoki T; Tanaka H; Kosaka S; Houchi H
    Biol Pharm Bull; 2014; 37(6):916-21. PubMed ID: 24882404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxorubicin and doxorubicinol: intra- and inter-individual variations of pharmacokinetic parameters.
    Jacquet JM; Bressolle F; Galtier M; Bourrier M; Donadio D; Jourdan J; Rossi JF
    Cancer Chemother Pharmacol; 1990; 27(3):219-25. PubMed ID: 2265458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Bayesian estimation of pharmacokinetic parameters.
    Tsuchiwata S; Mihara K; Yafune A; Ogata H
    Ther Drug Monit; 2005 Feb; 27(1):18-24. PubMed ID: 15665741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A limited sampling strategy for the study of pirarubicin pharmacokinetics in humans.
    Marchiset-Leca D; Leca FR; Galeani A; Noble A; Iliadis A
    Cancer Chemother Pharmacol; 1995; 36(3):233-8. PubMed ID: 7781144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer.
    Gauvin A; Pinguet F; Culine S; Astre C; Gomeni R; Bressolle F
    Clin Cancer Res; 2000 Jul; 6(7):2690-5. PubMed ID: 10914711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.